SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1987, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a diverse portfolio that includes anti-infectives, anti-diabetics, and cardiovascular medications, SMS Pharmaceuticals is recognised for its commitment to quality and innovation. The company’s state-of-the-art manufacturing facilities adhere to stringent regulatory standards, ensuring the delivery of high-quality products. Notable achievements include successful collaborations with global pharmaceutical firms and a strong market presence in Europe and the Americas. SMS Pharmaceuticals Ltd continues to drive advancements in healthcare, making significant contributions to the pharmaceutical landscape.
DitchCarbon Score
How does SMS Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SMS Pharmaceuticals Ltd's score of 25 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SMS Pharmaceuticals Ltd's reported carbon emissions
In 2024, SMS Pharmaceuticals Ltd reported total carbon emissions of approximately 42,378,970 kg CO2e from Scope 2 and 37,382,480 kg CO2e from Scope 1, alongside 200,610 kg CO2e from Scope 3. This marks a notable increase in emissions compared to 2023, where the company recorded about 28,551,170 kg CO2e in Scope 2, 32,757,700 kg CO2e in Scope 1, and 31,870 kg CO2e in Scope 3. Despite the rising emissions, SMS Pharmaceuticals has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company operates within the pharmaceutical industry, which is increasingly focusing on sustainability and carbon footprint reduction. As SMS Pharmaceuticals continues to navigate its environmental impact, it remains essential for the company to establish clear climate commitments and reduction strategies to align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 25,759,670 | 00,000,000 | 00,000,000 |
| Scope 2 | 31,505,800 | 00,000,000 | 00,000,000 |
| Scope 3 | 32,500 | 00,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SMS Pharmaceuticals Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
